Blood Donors Will Get Results of Coronavirus Antibody Test, Red Cross Says
Positive test result does not confirm immunity to the virus, and test is not meant to diagnose illness.
Miscellaneous Hematological Agents
FDA Grants First Approval of Convalescent Plasma Therapy in COVID-19 Patient
Houston Methodist first to receive eIND approval for convalescent plasma in individual patient.
Blood Testing Kit to Assess Nutrient Status Approved for At-Home Use
Based on the blood test results, dietitians will personalize a dietary supplement regimen to which the consumer can subscribe to. Consumers can also re-test periodically to ensure that they are receiving the supplements they need.
High-Dose Erythropoietin No Benefit for Extreme Preemies
No reduction found in risk for severe neurodevelopmental impairment or death at 2 years of age.
Luspatercept Mitigates Anemia in Lower-Risk Myelodysplastic Syndromes
Transfusion burden reduced in patients with lower-risk myelodysplastic syndromes with ring sideroblasts.
Patients Should Restart Blood Thinners After GI Bleed
Lower risk for ischemic events and death outweigh risk for another bleeding event
Aspirin May Slow Growth of Multiple Intracranial Aneurysms
Aspirin linked to decreased rate of aneurysm growth in patients with multiple intracranial aneurysms.
MPR Weekly Dose Podcast: Episode 8
All the top pharma and medicine news from this week in the time it takes you to sleep through one snooze of your alarm clock.
Methemoglobinemia Following Overuse of OTC Topical Pain Reliever
A report published in the New England Journal of Medicine describes the case of a 25-year-old woman who developed methemoglobinemia following the use of topical benzocaine. According to clinicians from the Miriam Hospital in Providence, RI, the patient presented with generalized weakness, fatigue, shortness of breath and skin discoloration. “Measurements of arterial blood gases included…
Treatment Granted Orphan Drug Status for Acute Radiation Syndrome
The Food and Drug Administration (FDA) has granted Orphan Drug designation to TP508 (rusalatide acetate; Chrysalis BioTherapeutics) for the treatment of acute radiation syndrome (ARS). ARS, also known as radiation sickness, is an acute illness caused by irradiation of the body due to high levels of nuclear radiation exposure. The illness affects multiple organ systems…
